Skip to main content
logo
NextCell Pharma AB (STO:NXTCL)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.9500
-0.0200 (-2.06%)
Jul 3, 2026, 5:16 PM CET

NextCell Pharma AB Revenue

NextCell Pharma AB had revenue of 2.78M SEK in the quarter ending March 31, 2026, a decrease of -2.85%. This brings the company's revenue in the last twelve months to 9.24M, down -2.17% year-over-year. In the year 2025, NextCell Pharma AB had annual revenue of 9.83M, down -11.13%.

Revenue (ttm)
9.24M
Revenue Growth
-2.17%
P/S Ratio
12.99
Revenue / Employee
385.14K
Employees
24
Market Cap
120.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.83M-1.23M-11.13%
Aug 31, 202511.06M-213.75K-1.90%
Aug 31, 202411.28M-2.68M-19.18%
Aug 31, 202313.96M7.73M124.03%
Aug 31, 20226.23M1.77M39.82%
Aug 31, 2021 Pro Pro Pro
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nanologica AB31.83M
Biovica International AB13.49M
Scandinavian ChemoTech AB12.61M
Spago Nanomedical AB4.38M
Simris Group AB (PUBL)1.88M
Alligator Bioscience AB520.00K
Diamyd Medical AB432.00K
OncoZenge AB71.00K
Revenue Rankings

NextCell Pharma AB News

More News